Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,776 announcements in the last 12 months · page 75 of 108
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | Accenture plc (ACN) | Q2 FY2026 | $18.04B | 8.3% | $1.83B | 2.93 | 3.9% | 8-K |
| 2026-03-19 | Aebi Schmidt Holding AG (AEBI) | Q4 FY2025 | $528.4M | 77.2% | $8.8M | 0.11 | — | 8-K |
| 2026-03-19 | Alumis Inc. (ALMS) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Assembly Biosciences, Inc. (ASMB) | Q4 FY2025 | $42.5M | 477.3% | $22.1M | 1.31 | — | 8-K |
| 2026-03-19 | Aveanna Healthcare Holdings, Inc. (AVAH) | Q4 FY2026 | $662.5M | — | $178.8M | 0.80 | — | 8-K |
| 2026-03-19reported in filing | Avalon Holdings Corp. (AWX) | Q4 FY2025 | $21.5M | 21.7% | $-356,000 | — | — | 8-K |
| 2026-03-19 | Biofrontera Inc. (BFRI) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Cardinal Infrastructure Group Inc. (CDNL) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Curis Inc. (CRIS) | Q4 FY2025 | $1.1M | -66.0% | $19.4M | 1.23 | — | 8-K |
| 2026-03-19 | Torrid Holdings Inc. (CURV) | Q4 FY2025 | $236.2M | -14.3% | $-8.1M | -0.08 | — | 8-K |
| 2026-03-19 | Duluth Holdings Inc. (DLTH) | Q4 FY2026 | $215.9M | -10.5% | $7.7M | 0.22 | — | 8-K |
| 2026-03-19 | Darden Restaurants Inc. (DRI) | Q3 FY2026 | $3.35B | 5.9% | $306.8M | 2.65 | -3.3% | 8-K |
| 2026-03-19reported in filing | DarioHealth Corp. (DRIO) | Q4 FY2025 | $5.2M | -31.2% | $-9.0M | — | — | 8-K |
| 2026-03-19 | Destination Xl Group, Inc. (DXLG) | Q4 FY2025 | $112.1M | -6.0% | $-29.6M | -0.54 | — | 8-K |
| 2026-03-19 | electroCore, Inc. (ECOR) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Eton Pharmaceuticals, Inc. (ETON) | Q4 FY2025 | $21.3M | 82.7% | $1.5M | — | — | 8-K |
| 2026-03-19 | Fedex Corp. (FDX) | Q3 FY2026 | $24.00B | 8.3% | $1.06B | 4.41 | 17.3% | 8-K |
| 2026-03-19 | Gemini Space Station, Inc. (GEMI) | Q4 FY2025 | $60.3M | 39.4% | $-140.8M | -1.22 | — | 8-K |
| 2026-03-19 | Genie Energy Ltd. (GNE) | Q4 FY2025 | $121.6M | 18.2% | $3.8M | 0.14 | -48.4% | 8-K |
| 2026-03-19 | Gold Resource Corp. (GORO) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Intellicheck, Inc. (IDN) | Q4 FY2025 | $6.6M | 11.8% | $1.6M | 0.07 | 192.0% | 8-K |
| 2026-03-19 | Chicago Atlantic BDC, Inc. (LIEN) | Q4 FY2025 | — | — | $8.2M | 0.36 | 2.4% | 8-K |
| 2026-03-19 | Mount Logan Capital Inc. (MLCI) | Q4 FY2025 | $9.9M | 10.6% | $-39.8M | -3.11 | — | 8-K |
| 2026-03-19 | Mereo BioPharma Group plc (MREO) | Q4 FY2025 | $0 | — | $-7.4M | -0.01 | — | 8-K |
| 2026-03-19 | Nacco Industries Inc. (NC) | Q4 FY2025 | $66.8M | -5.2% | $-3.8M | -0.51 | -150.0% | 8-K |
| 2026-03-19 | FiscalNote Holdings, Inc. (NOTE) | Q4 FY2025 | $22.2M | -24.7% | $-22.9M | -1.40 | — | 8-K |
| 2026-03-19 | Pedevco Corp. (PED) | Q4 FY2025 | $23.1M | 118.2% | $-8.5M | — | — | 8-K |
| 2026-03-19 | Planet Labs PBC (PL) | Q4 FY2026 | $86.8M | 41.1% | $-152.5M | -0.48 | — | 8-K |
| 2026-03-19 | Pelthos Therapeutics Inc. (PTHS) | Q4 FY2025 | $9.4M | — | $-21.7M | -6.85 | — | 8-K |
| 2026-03-19 | Rci Hospitality Holdings, Inc. (RICK) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Solo Brands, Inc. (SBDS) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-19 | Scholastic Corp. (SCHL) | Q3 FY2026 | $329.1M | -1.9% | $62.5M | 2.55 | — | 8-K |
| 2026-03-19 | Sky Harbour Group Corp (SKYH) | Q4 FY2025 | $8.1M | 73.6% | $9.6M | — | — | 8-K |
| 2026-03-19 | Snail, Inc. (SNAL) | Q4 FY2025 | $25.1M | -4.2% | $-862,154 | — | — | 8-K |
| 2026-03-19 | SUNation Energy, Inc. (SUNE) | Q4 FY2025 | $27.2M | 77.0% | $2.6M | 0.77 | — | 8-K |
| 2026-03-19 | Theravance Biopharma, Inc. (TBPH) | Q4 FY2025 | $45.9M | 144.7% | $61.0M | 1.15 | — | 8-K |
| 2026-03-19 | Titan Machinery Inc. (TITN) | Q4 FY2026 | $641.8M | -15.5% | $-36.2M | -1.59 | — | 8-K |
| 2026-03-19 | Tejon Ranch Co. (TRC) | Q4 FY2025 | $21.1M | 17.7% | $1.6M | 0.06 | -65.1% | 8-K |
| 2026-03-19 | Taysha Gene Therapies, Inc. (TSHA) | Q4 FY2025 | $5.5M | 171.3% | $-27.9M | -0.08 | — | 8-K |
| 2026-03-18 | Accelerant Holdings (ARX) | Q4 FY2025 | $248.4M | 30.3% | — | 0.44 | 300.0% | 8-K |
| 2026-03-18 | American Vanguard Corp. (AVD) | Q4 FY2025 | $150.7M | -9.0% | $-28.2M | -0.99 | — | 8-K |
| 2026-03-18reported in filing | Envela Corp (ELA) | Q4 FY2025 | $80.5M | 66.6% | $6.0M | 0.23 | 274.4% | 8-K |
| 2026-03-18 | EquipmentShare.com Inc (EQPT) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-18 | 4D Molecular Therapeutics, Inc. (FDMT) | Q4 FY2025 | — | — | $19.4M | 0.30 | — | 8-K |
| 2026-03-18reported in filing | Future FinTech Group Inc. (FTFT) | Q4 FY2025 | $1.3M | 868.2% | $66,815 | — | — | 8-K |
| 2026-03-18reported in filing | Giftify, Inc. (GIFT) | Q4 FY2025 | $21.2M | -12.2% | $-2.2M | -0.07 | — | 8-K |
| 2026-03-18 | General Mills Inc. (GIS) | Q3 FY2026 | $4.44B | -8.4% | $303.1M | 0.56 | -50.0% | 8-K |
| 2026-03-18 | Harte Hanks Inc. (HHS) | Q4 FY2025 | $39.9M | -15.4% | $2.2M | 0.30 | — | 8-K |
| 2026-03-18 | Hyperfine, Inc. (HYPR) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-18 | Jabil Inc. (JBL) | Q2 FY2026 | $8.28B | 23.1% | $223.0M | 2.08 | 96.2% | 8-K |
| 2026-03-18 | Lifeward Ltd. (LFWD) | Q4 FY2025 | $5.1M | -32.7% | $-5.3M | — | — | 8-K |
| 2026-03-18 | Micron Technology Inc. (MU) | Q2 FY2026 | $23.86B | 196.3% | $13.79B | 12.07 | 756.0% | 8-K |
| 2026-03-18 | Natural Gas Services Group Inc. (NGS) | Q4 FY2025 | $46.1M | 13.5% | $4.1M | 0.32 | 42.5% | 8-K |
| 2026-03-18reported in filing | PGIM Private Credit Fund (PGIM) | Q4 FY2025 | — | — | $6.9M | — | — | 8-K |
| 2026-03-18 | Protalix BioTherapeutics, Inc. (PLX) | Q4 FY2025 | $9.1M | -49.9% | $-5.5M | -0.07 | -211.0% | 8-K |
| 2026-03-18 | Red Cat Holdings, Inc. (RCAT) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-18 | Sachem Capital Corp. (SACH) | Q4 FY2025 | — | — | $2.5M | 0.05 | — | 8-K |
| 2026-03-18 | Tecogen Inc. (TGEN) | Q4 FY2025 | $5.3M | -12.5% | $-4.0M | -0.13 | — | 8-K |
| 2026-03-18 | Usio, Inc. (USIO) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-18 | Williams Sonoma Inc. (WSM) | Q4 FY2025 | $2.36B | -4.3% | $368.0M | 3.04 | -7.2% | 8-K |
| 2026-03-18 | XOMA Royalty Corp (XOMA) | Q4 FY2025 | $13.8M | 57.9% | $6.1M | 0.34 | — | 8-K |
| 2026-03-17 | Andersen Group Inc. (ANDG) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-17 | Bicycle Therapeutics PLC (BCYC) | Q4 FY2025 | $48.0M | 1193.3% | $-20.2M | -0.29 | — | 8-K |
| 2026-03-17 | Bakkt, Inc. (BKKT) | Q4 FY2025 | — | — | $-85.3M | -3.90 | — | 8-K |
| 2026-03-17 | Comstock Holding Companies, Inc. (CHCI) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-17 | Core Laboratories Inc. (CLB) | Q4 FY2025 | $138.3M | 7.0% | $4.9M | 0.11 | -30.7% | 8-K |
| 2026-03-17reported in filing | Coda Octopus Group, Inc. (CODA) | Q1 FY2026 | $6.7M | 28.8% | $930,723 | 0.08 | 0.0% | 8-K |
| 2026-03-17 | Citi Trends Inc (CTRN) | Q4 FY2025 | $230.4M | 9.1% | — | 0.90 | — | 8-K |
| 2026-03-17 | Consolidated Water Co. Ltd. (CWCO) | Q4 FY2025 | $24.8M | 174.7% | $2.9M | 0.18 | 98.7% | 8-K |
| 2026-03-17reported in filing | Crimson Wine Group, Ltd (CWGL) | Q4 FY2025 | $20.3M | -11.3% | $737,000 | 0.04 | -43.9% | 8-K |
| 2026-03-17 | Dragonfly Energy Holdings Corp. (DFLI) | Q4 FY2025 | $13.1M | 6.9% | $-45.0M | — | — | 8-K |
| 2026-03-17 | Greystone Housing Impact Investors LP (GHI) | Q4 FY2025 | $15.0M | -33.6% | $-5.8M | — | — | 8-K |
| 2026-03-17 | Gossamer Bio, Inc. (GOSS) | Q4 FY2025 | $13.8M | 47.1% | $-47.2M | -0.20 | — | 8-K |
| 2026-03-17 | Intelligent Protection Management Corp. (IPM) | Q4 FY2025 | $6.1M | 2091.6% | $-631,968 | -0.05 | — | 8-K |
| 2026-03-17 | IZEA Worldwide, Inc. (IZEA) | Q4 FY2025 | $6.1M | -44.9% | $-1.2M | -0.06 | — | 8-K |
| 2026-03-17 | Kestra Medical Technologies, Ltd. (KMTS) | Q3 FY2026 | $24.6M | 62.7% | $-34.2M | -0.61 | — | 8-K |
| 2026-03-17 | lululemon athletica inc. (LULU) | Q4 FY2025 | $3.64B | 0.8% | $586.9M | 5.01 | -18.4% | 8-K |
| 2026-03-17reported in filing | Maison Solutions Inc. (MSS) | Q3 FY2026 | $29.5M | -8.6% | $-5.2M | -0.21 | -450.0% | 8-K |
| 2026-03-17reported in filing | Marwynn Holdings, Inc. (MWYN) | Q3 FY2026 | $1.4M | 121.9% | $-548,336 | -0.03 | — | 8-K |
| 2026-03-17 | Energy Vault Holdings, Inc. (NRGV) | Q4 FY2025 | $153.3M | 358.0% | $-20.7M | -0.12 | — | 8-K |
| 2026-03-17 | Paradium.AI, Inc. (PAAI) | Q4 FY2025 | $28.2M | -22.0% | $5.3M | 0.11 | -23.0% | 8-K |
| 2026-03-17 | Pharma-Bio Serv, Inc. (PBSV) | Q1 FY2026 | $2.3M | -7.1% | $32,860 | 0.00 | — | 8-K |
| 2026-03-17reported in filing | Phoenix Energy One, LLC (PHXE-P) | Q4 FY2025 | $218.6M | 115.0% | $33.3M | — | — | 8-K |
| 2026-03-17 | PSQ Holdings, Inc. (PSQH) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-17reported in filing | George Risk Industries, Inc. (RSKIA) | Q3 FY2026 | $5.7M | 15.2% | $2.5M | 0.51 | 54.5% | 8-K |
| 2026-03-17 | Comscore, Inc. (SCOR) | Q4 FY2025 | $93.5M | -1.5% | $3.0M | — | — | 8-K |
| 2026-03-17 | Urban One, Inc. (UONE) | Q4 FY2025 | $97.8M | -16.5% | $-54.4M | — | — | 8-K |
| 2026-03-17reported in filing | Value Line Inc. (VALU) | Q3 FY2026 | $8.3M | -7.7% | $5.9M | — | — | 8-K |
| 2026-03-17 | Vireo Growth Inc. (VREOF) | Q4 FY2025 | $104.5M | 317.7% | $-20.4M | -0.02 | — | 8-K |
| 2026-03-17reported in filing | Airwa Inc. (YYAI) | Q3 FY2026 | $7.0M | 113.1% | $-1.6M | — | — | 8-K |
| 2026-03-16 | Agenus Inc. (AGEN) | Q4 FY2025 | $34.2M | 27.5% | — | -0.37 | — | 8-K |
| 2026-03-16 | Airsculpt Technologies, Inc. (AIRS) | Q4 FY2025 | $33.4M | -14.6% | $1.3M | 0.02 | — | 8-K |
| 2026-03-16 | Ampco Pittsburgh Corp. (AP) | Q4 FY2025 | $104.4M | 6.8% | $-57.7M | -2.85 | -1935.0% | 8-K |
| 2026-03-16 | Atara Biotherapeutics, Inc. (ATRA) | Q4 FY2025 | $1.6M | -95.1% | $-3.4M | -0.25 | — | 8-K |
| 2026-03-16 | Bally's Corp (BALY) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-16 | Black Diamond Therapeutics, Inc. (BDTX) | Q4 FY2025 | $0 | — | $-15.1M | -0.26 | — | 8-K |
| 2026-03-16 | BNB Standard Corp (BNC) | Q4 FY2025 | $7.3M | 1657.0% | $-106.6M | -1.92 | — | 8-K |
| 2026-03-16 | Bitcoin Depot Inc. (BTMCQ) | Q4 FY2025 | $116.0M | -15.2% | $-22.0M | — | — | 8-K |
| 2026-03-16 | Comtech Telecommunications Corp. (CMTL) | Q2 FY2026 | $106.8M | -15.7% | $-13.6M | -0.68 | — | 8-K |
| 2026-03-16 | CytomX Therapeutics, Inc. (CTMX) | Q4 FY2025 | $663,000 | -98.3% | $-26.5M | — | — | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.